Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Monthly premiums for Medicare Advantage plans are expected to decrease again in 2021, as enrollment in the privatized version of traditional Medicare climbs.
The Trump administration could move forward with a policy that ties Medicare payments for outpatient drugs to foreign prices by upending the buy-and-bill payment system, according to the administration's draft plan.
The Trump administration has rolled out a slew of policies aimed at offering greater flexibility to payers and providers amid COVID-19. But what changes are likely to stick around long-term?
House Democrats' bill to extend funding for the federal government through mid-December included a provision that would relax repayment terms for COVID-19 Medicare loans.
One of the overriding questions in the upcoming election is: What will happen to health care under a Trump or a Biden presidency? And what would a public option do to health insurance brokers?
The ranks of the nation’s uninsured continued to grow last year, even before the arrival of the coronavirus pandemic that’s devastated the economy, new federal data show.
COVID-19 relief legislation that lets providers in some cases set their own prices on COVID tests has resulted in charges as high as $14,750, a new study finds.
High prices, widening gaps in insurance coverage and racial disparities in outcomes are tied to wide state-level variation in health care performance that will likely be exacerbated by the coronavirus pandemic, according to a sweeping new report from The Commonwealth Fund.
President Trump signed an executive order Sunday that he says lowers prescription drug prices "by putting America first," but experts said the move is unlikely to have any immediate impact.
Before the coronavirus pandemic shut down the entertainment industry in March, Jeffrey Farber had a steady flow of day jobs in film and television, including work on “Hunters” and “Blue Bloods.” But when theaters, movies and TV shows stopped production, not only did Farber lose his acting income